| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-07 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
| mRNA |
GNF-2 |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
0.0006 |
| mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |